GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asymchem Laboratories Tianjin Co Ltd (SZSE:002821) » Definitions » Enterprise Value

Asymchem Laboratories Tianjin Co (SZSE:002821) Enterprise Value : ¥21,947 Mil (As of Dec. 14, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Asymchem Laboratories Tianjin Co Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Asymchem Laboratories Tianjin Co's Enterprise Value is ¥21,947 Mil. Asymchem Laboratories Tianjin Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was ¥837 Mil. Therefore, Asymchem Laboratories Tianjin Co's EV-to-EBIT ratio for today is 26.24.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Asymchem Laboratories Tianjin Co's Enterprise Value is ¥21,947 Mil. Asymchem Laboratories Tianjin Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was ¥837 Mil. Therefore, Asymchem Laboratories Tianjin Co's EV-to-EBITDA ratio for today is 26.24.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Asymchem Laboratories Tianjin Co's Enterprise Value is ¥21,947 Mil. Asymchem Laboratories Tianjin Co's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was ¥5,582 Mil. Therefore, Asymchem Laboratories Tianjin Co's EV-to-Revenue ratio for today is 3.93.


Asymchem Laboratories Tianjin Co Enterprise Value Historical Data

The historical data trend for Asymchem Laboratories Tianjin Co's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asymchem Laboratories Tianjin Co Enterprise Value Chart

Asymchem Laboratories Tianjin Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29,528.74 70,460.16 108,236.97 47,502.90 34,078.69

Asymchem Laboratories Tianjin Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47,037.01 34,078.69 22,978.34 16,780.50 23,766.17

Competitive Comparison of Asymchem Laboratories Tianjin Co's Enterprise Value

For the Biotechnology subindustry, Asymchem Laboratories Tianjin Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asymchem Laboratories Tianjin Co's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Asymchem Laboratories Tianjin Co's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Asymchem Laboratories Tianjin Co's Enterprise Value falls into.



Asymchem Laboratories Tianjin Co Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Asymchem Laboratories Tianjin Co's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Asymchem Laboratories Tianjin Co's Enterprise Value for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Asymchem Laboratories Tianjin Co  (SZSE:002821) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Asymchem Laboratories Tianjin Co's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=21947.407/836.528
=26.24

Asymchem Laboratories Tianjin Co's current Enterprise Value is ¥21,947 Mil.
Asymchem Laboratories Tianjin Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥837 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Asymchem Laboratories Tianjin Co's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=21947.407/836.528
=26.24

Asymchem Laboratories Tianjin Co's current Enterprise Value is ¥21,947 Mil.
Asymchem Laboratories Tianjin Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥837 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Asymchem Laboratories Tianjin Co's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=21947.407/5582.421
=3.93

Asymchem Laboratories Tianjin Co's current Enterprise Value is ¥21,947 Mil.
Asymchem Laboratories Tianjin Co's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥5,582 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Asymchem Laboratories Tianjin Co Enterprise Value Related Terms

Thank you for viewing the detailed overview of Asymchem Laboratories Tianjin Co's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Asymchem Laboratories Tianjin Co Business Description

Traded in Other Exchanges
Address
No. 6 Dongting Third Street, Economic and Technological Development Zone, Tianjin, CHN, 300457
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development manufacturing organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing which focuses on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
Executives
Chen Chao Yong Executives
Hong Liang Directors, executives
Zhou Yan Executives
Xu Xiang Ke Directors, executives
Zhang Ting Director
Jiang Ying Wei Executives
Zhang Da Directors, executives
Xiao Yi Executives
Huang Xiao Lian Executives
Yang Jing Director
Executives

Asymchem Laboratories Tianjin Co Headlines

No Headlines